Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis

Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis

Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC), but response rates remain heterogeneous, and reliable predictive biomarkers are lacking. Recent studies suggest that androgen receptor (AR) signaling plays a role in regulating...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lin Yang, Hai Huang, Qiong Wang, Peng Wu, Ke Chen, Weijia Li, Bisheng Cheng, Jilin Wu, Jianghua Yang, WenTai Shangguan, Wenxue Huang, Cunzhen Ma, Zhuohang Li, Boyuan Sun
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-02-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/2/e011154.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of immunotherapy in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma: a multicenter retrospective study
by: Xiongwen Yang, et al.
Published: (2025-01-01)

Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review
by: Yuke Wu, et al.
Published: (2024-07-01)

Microbiome: A New Perspective on Immunotherapy for Metastatic Tumors
by: Hongquan Liu, et al.
Published: (2025-05-01)

Immunotherapy in metastatic prostate cancer
by: Liam Dwyer, et al.
Published: (2025-06-01)

Aldo-Keto Reductases in the Eye
by: Shun Ping Huang, et al.
Published: (2010-01-01)

Biochemical and Structural Characterization of Glyoxylate Reductase/Hydroxypyruvate Reductase from <i>Bacillus subtilis</i>
by: Thang Quyet Nguyen, et al.
Published: (2025-03-01)

Severe immunotherapy-related thrombocytopenia in metastatic bone cancer: a multicenter retrospective case series highlighting early recognition and management
by: Qian Gao, et al.
Published: (2025-05-01)

RC48-ADC monotherapy or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma with HER2 low and null expression: a multicenter, real-world, retrospective study
by: Daining Wang, et al.
Published: (2025-04-01)

Peripheral eosinophils and immunotherapy response in patients with recurrent or metastatic HNSCC
by: Yuexiang Qin, et al.
Published: (2025-05-01)

Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis
by: Haydn Kissick, et al.
Published: (2024-03-01)

Number of Prescription Medications and Overall Survival in Metastatic Castrate-Resistant Prostate Cancer
by: Carley R. Pickett, et al.
Published: (2024-01-01)

Gut markers for metastatic melanoma receiving immunotherapy
by: Guoping Ou, et al.
Published: (2025-07-01)

Efficacy and Safety of Bevacizumab Biosimilar (Encoda) Compared With Reference Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer: A Multicenter, Real-World Study
by: Han Shan, et al.
Published: (2024-12-01)

Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
by: Maliazurina B. Saad, et al.
Published: (2025-07-01)

The evolving landscape of genetic biomarkers for immunotherapy in primary and metastatic breast cancer
by: Liang Jin, et al.
Published: (2025-03-01)

Advances in Immunotherapy for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2017-01-01)

INTRAPLEURAL IMMUNOTHERAPY FOR METASTATIC PLEURISIES IN PATIENTS WITH BREAST CANCER
by: K. S. Titov, et al.
Published: (2014-09-01)

Immunological barriers to immunotherapy in primary and metastatic breast cancer
by: Mara De Martino, et al.
Published: (2021-06-01)

Marked Erythroblast Haemophagocytosis in Association With Immunotherapy for Metastatic Melanoma
by: Tamasine Stewart, et al.
Published: (2025-06-01)

Radiotherapy improves the clinical outcomes of recurrent or metastatic head and neck cancers treated with immunotherapy
by: Yanshuang Cheng, et al.
Published: (2025-06-01)

The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer
by: Mingxiu Ju, et al.
Published: (2024-10-01)

Structure of dimerized assimilatory NADPH-dependent sulfite reductase reveals the minimal interface for diflavin reductase binding
by: Behrouz Ghazi Esfahani, et al.
Published: (2025-03-01)

Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma
by: Valeria V. Nazarova, et al.
Published: (2025-05-01)

Pembrolizumab versus bevacizumab plus modified FOLFOX6 in metastatic MSI-H/dMMR colorectal cancer: a multicenter retrospective study with CT evaluation
by: Jiaqi Chen, et al.
Published: (2025-04-01)

Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma
by: Rui-Ling Xie, et al.
Published: (2025-04-01)

Prescription patterns of herbal medicine for menopausal disorders in major Korean medicine hospitals: A multicenter retrospective study
by: Hye Won Lee, et al.
Published: (2021-09-01)

Reducing phosphorylation of nitrate reductase improves nitrate assimilation in rice
by: Rui-cai HAN, et al.
Published: (2022-01-01)

Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
by: Marketa Skalickova, et al.
Published: (2025-01-01)

The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review
by: Hong-Xia Cui, et al.
Published: (2025-05-01)

Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects
by: Zahid Rafiq, et al.
Published: (2025-01-01)

Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy
by: Haolun Ding, et al.
Published: (2025-01-01)

Disparities in Immunotherapy Use Prior to First-Line Approval for Metastatic Hepatocellular Carcinoma in the United States
by: Manav Shah, et al.
Published: (2025-02-01)

Tumor microenvironment–responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy
by: Qi Yang, et al.
Published: (2025-01-01)

Interim C-reactive protein levels predict the prognosis of patients with metastatic colorectal cancer receiving immunotherapy: a retrospective cohort study
by: Hai-Yan Fu, et al.
Published: (2025-07-01)

Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats
by: Lixia Ji, et al.
Published: (2017-01-01)

Prescription
by: Tanis MacDonald
Published: (2021-06-01)

A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy
by: Haitao Yuan, et al.
Published: (2025-06-01)

Current trends in the immunotherapy of metastatic and recurrent squamous cell carcinoma of the head and neck
by: Yu. V. Kostalanova, et al.
Published: (2020-11-01)

Chemo-immunotherapy sequential with radiotherapy in advanced or metastatic esophageal squamous cell carcinoma
by: Xiang Han, et al.
Published: (2025-12-01)

Immunotherapy in Metastatic Mucosal Melanoma with Disseminated Intravascular Coagulation: A Case of Success
by: Helena Luna Pais, et al.
Published: (2021-01-01)